The Geron Corp. (GERN) Issues Earnings Results, Beats Estimates By $0.04 EPS

What Historical Figures Say About Geron Corporation (NASDAQ: GERN)? For the current quarter Geron Corporation (NASDAQ:GERN) has high EPS estimates of $-0.04 in contradiction of low EPS estimates of $-0.05. The biopharmaceutical company reported ($0.04) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.05) by $0.01. The value of the company's investment in Geron Corporation went from $97,282,000 to $3,172,000 a change of $94,110,000 since the last quarter.

Analysts have given a mean recommendation of 2.70 on this stock (A rating of less than 2 means buy, "hold" within the 3 range, "sell" within the 4 range, and "strong sell" within the 5 range). Geron Corporation presently has an average rating of "Hold" and a consensus target price of $3.75.

Geron Corporation (GERN) has risen 4.28% since then. BidaskClub downgraded shares of Geron Corporation from a "hold" rating to a "sell" rating in a research report on Saturday, August 5th.

Taking a broader look at the analyst consensus, according to 2 analysts Geron Corporation (NASDAQ:GERN)'s price will reach at $3.75 during 52 weeks. The stock ended last trade at $1.95 a share and the price is up more than -5.80% so far this year.

According to 3 stock analysts, Geron Corporation, is being kept at an average Hold, rating, with at least 17.53% of shares outstanding that are now legally short sold. The volume of FRED witnessed a shift from 2.9 million shares, based on a 50-day average, to 0.93 million shares.

BTIG Research "Initiates Coverage on" Geron Corporation (NASDAQ:GERN) in a research note issued to investors on 8/19/16 to Neutral. This works out to a decrease of -10.53% compared to last year's earnings. The stock now has a consensus rating of "Hold" and a consensus price target of $3.75. If you are viewing this report on another site, it was illegally copied and reposted in violation of United States and worldwide copyright and trademark law. The original version of this article can be read at

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. BlackRock Investment Management LLC boosted its stake in Geron 4.0% in the second quarter. Parametric Portfolio Associates LLC boosted its holdings in shares of Geron Corporation by 59.4% in the 2nd quarter. IHT Wealth Management LLC bought a new position in shares of Geron Corporation in the second quarter worth about $122,000. Insider ownership during the latest quarter increased by a net of 18206 shares, indicating that GERN's key executives are feeling more bullish about the stock than they did three months ago. Janney Montgomery Scott LLC now owns 132,200 shares of the biopharmaceutical company's stock valued at $354,000 after buying an additional 65,100 shares in the last quarter.

Currently Geron Corporation (NASDAQ:GERN)'s shares owned by insiders are 0.1%, whereas shares owned by institutional owners are 39.2%.

Geron Corporation (Geron), launched on November 28, 1990, is a biopharmaceutical company, which supports the clinical stage development of a telomerase inhibitor, Imetelstat, in hematologic myeloid malignancies by Janssen Biotech, Inc. Using its nucleic acid chemistry, Geron designed Imetelstat to be an oligonucleotide that binds with high affinity to the ribonucleic acid (RNA) template of telomerase, thereby directly inhibiting telomerase activity.

Like this


14 November 2017
Government must fund expansion of Customs system, say MPs
It warned that using uncertainty over the outcome of Brexit negotiations as an excuse to hold back from action would not work. It was "deeply troubling" that HMRC did not have the funding to develop customs systems for Brexit or plan contingencies.

14 November 2017
Minerva Punjab, Mohun Bagan to kickstart 2017-18 I-League season
However, the release of the fixtures just 11 days ahead of the actual start of the league does not bode well for the tournament. For the first time since the inception of ISL in 2014, the franchise league and I-League will be held concurrently this season.

14 November 2017
Financial Indicators and Analyst Sentiment for Intel Corporation
Intel Corporation (INTC ) now has 4.68 million shares outstanding, which means that its market capitalization is $217.49B. Garrison Bradford & Associates Inc holds 10.79% of its portfolio in Blackstone Mortgage Trust Inc for 394,796 shares.

14 November 2017
Boeing Says Middle East Could Demand 3350 New Airplanes Over 20 Years
"Traffic growth in the Middle East is expected to grow at 5.6 percent annually during the next 20 years", said Randy Tinseth, Vice President of Marketing, Boeing Commercial Airplanes.

14 November 2017
Analyst Research and Ratings: JAKKS Pacific, Inc. (JAKK), OncoSec Medical Incorporated (ONCS)
Latest trading price was 139.65% upbeat to its 50-day moving average and above 140.03% to its 200-day moving average. Simply a stock experiencing a high level of volatility has a higher ATR, and a low volatility stock has a lower ATR.

14 November 2017
Federer back in the groove at Tour Finals
He came into 2017 having missed half of last season due to fitness problems and was without a Grand Slam title since 2012. Federer, the oldest qualifier since 1970, looked aghast as two break points went begging at 3-3, then another two at 4-4.

14 November 2017
Are Traders Shorting Medical Properties Trust, Inc. (NYSE:MPW) Shares?
The real estate investment trust reported $0.33 EPS for the quarter, topping the Zacks' consensus estimate of $0.32 by $0.01. It improved, as 19 investors sold MPW shares while 71 reduced holdings. 57 funds opened positions while 139 raised stakes.

14 November 2017
I-5 in Del Mar reopens after deadly crash
About half a mile south of that collision, a pickup truck crashed into several vehicles about 4:45 a.m. Moments later, a black Mercedes hit the Toyota, which was still in traffic lanes.

14 November 2017
USA security officials arrive in Israel to discuss Syria border deal
The presence of Iran in Syria is legitimate, Lavrov was quoted as saying by another agency, Interfax. Curtiss Scaparrotti, head of the USA army's European Command, to discuss Iranian moves in Syria.

14 November 2017
Former Pharmaceutical Company Executive Picked to Run HHS
The HHS is responsible for advising the President on matters of health, welfare, and income security programmes. He would also help the Trump administration to dismantle Obamacare and crack down on drug prices.